Vanda Pharmaceuticals Inc. (VNDA) › EPS (Diluted)Vanda Pharmaceuticals Inc. (VNDA) — EPS (Diluted)Annual figures by period end, from SEC filings.2009-12-31: $-1.332010-12-31: $0.252011-12-31: $-0.352012-12-31: $-1.012013-12-31: $-0.692014-12-31: $0.552015-12-31: $-0.942016-12-31: $-0.412017-12-31: $-0.352018-12-31: $0.482019-12-31: $2.112020-12-31: $0.422021-12-31: $0.582022-12-31: $0.112023-12-31: $0.042024-12-31: $-0.332025-12-31: $-3.74$-3.742009-12-31EPS (Diluted) (USD/shares)2025-12-31Period endedEPS (Diluted)Change YoYSource filing2025-12-31$-3.74—2026-02-12From 2025-01-012024-12-31$-0.33-925.0%2026-02-12From 2024-01-012023-12-31$0.04-63.6%2026-02-12From 2023-01-012022-12-31$0.11-81.0%2025-02-14From 2022-01-012021-12-31$0.58+38.1%2024-02-08From 2021-01-012020-12-31$0.42-80.1%2023-02-09From 2020-01-012019-12-31$2.11+339.6%2022-02-24From 2019-01-012018-12-31$0.48—2021-02-11From 2018-01-012017-12-31$-0.35—2020-02-26From 2017-01-012016-12-31$-0.41—2019-02-19From 2016-01-012015-12-31$-0.94-270.9%2018-02-15From 2015-01-012014-12-31$0.55—2017-02-17From 2014-01-012013-12-31$-0.69—2016-02-12From 2013-01-012012-12-31$-1.01—2015-03-13From 2012-01-012011-12-31$-0.35-240.0%2014-02-25From 2011-01-012010-12-31$0.25—2013-02-26From 2010-01-012009-12-31$-1.33—2012-03-09From 2009-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeTotal AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)